Căutare | Redinv

Vivian James a adăugat un fișier Health
2025-12-17 05:52:49 -

Creative Biostructure Upgrades Liposome Service to Enable Tailored Drug Delivery Solutions
Amid the swift progress in global drug delivery innovations, Creative Biostructure, a top-tier service provider in structural biology and nanomedicine, revealed today an extensive upgrade to its liposome service. This enhancement is set to deliver more nuanced and tailored liposome production services for corporate clients, addressing needs from early-stage research to clinical application...

0 Commentarii 0 Distribuiri 1208 Views

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Becky Davis a adăugat un fișier Alte
2025-12-31 06:26:20 -

How are Liposomes Different from Micelles?
What are Liposomes? Liposome is an artificial carrier membrane. In the water, the hydrophilic head of the phospholipid molecule is inserted into the water, and the hydrophobic tail of the liposome extends to the air, and after agitation, a spherical liposome of bilayer lipid molecules is formed. This bilayer structure is the same as the skin cell membrane structure, which helps the skin to...

0 Commentarii 0 Distribuiri 113 Views

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Becky Davis a adăugat un fișier Alte
2025-12-31 06:23:21 -

How CROs and Biotech Firms Use Pomalidomide Derivatives for Rapid PROTAC Screening
Contract research organizations and boutique biotech groups have developed pomalidomide derivatives into the most widely used plug-and-play CRBN recruiters: the scaffold provides a clean departure point, gram-scale commercial availability and a largely 'greyed' intellectual-property landscape. Stocking a freezer full of pre-functionalized C4- and C5-linker congeners (acetamides,...

0 Commentarii 0 Distribuiri 122 Views

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Becky Davis a adăugat un fișier Alte
2025-12-31 06:29:37 -

The Development Process of DUBTAC
The use of Proteolysis Targeting Chimeras (PROTACs) to degrade dysfunctional proteins has shown great potential to target proteins that were previously considered "undruggable", and several projects have entered clinical evaluation worldwide. Aberrant protein degradation, in fact, is also a pathogenic mechanism in some diseases, such as cystic fibrosis (CF) and some forms of cancer....

0 Commentarii 0 Distribuiri 106 Views

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!